Gersande Lena
Centre national de la recherche scientifique
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Gersande Lena.
Journal of Medicinal Chemistry | 2008
Gersande Lena; Joseph A. Trapani; Vivien R. Sutton; Annette Ciccone; Kylie A. Browne; Mark J. Smyth; William A. Denny; Julie A. Spicer
Dihydrofuro[3,4-c]pyridinones are the first class of small molecules reported to inhibit the cytolytic effects of the lymphocyte toxin perforin. A lead structure was identified from a high throughput screen, and a series of analogues were designed and prepared to explore structure-activity relationships around the core bicyclic thioxofuropyridinone and pendant furan ring. This resulted in the identification of a submicromolar inhibitor of the perforin-induced lysis of Jurkat T-lymphoma cells.
Journal of Medicinal Chemistry | 2013
Julie A. Spicer; Gersande Lena; Dani M. Lyons; Kristiina M. Huttunen; Christian Miller; Patrick D. O'Connor; Matthew Bull; Nuala A. Helsby; Stephen M.F. Jamieson; William A. Denny; Annette Ciccone; Kylie A. Browne; Jamie A. Lopez; Jesse A. Rudd-Schmidt; Ilia Voskoboinik; Joseph A. Trapani
A series of novel 5-arylidene-2-thioxoimidazolidin-4-ones were investigated as inhibitors of the lymphocyte-expressed pore-forming protein perforin. Structure–activity relationships were explored through variation of an isoindolinone or 3,4-dihydroisoquinolinone subunit on a fixed 2-thioxoimidazolidin-4-one/thiophene core. The ability of the resulting compounds to inhibit the lytic activity of both isolated perforin protein and perforin delivered in situ by natural killer cells was determined. A number of compounds showed excellent activity at concentrations that were nontoxic to the killer cells, and several were a significant improvement on previous classes of inhibitors, being substantially more potent and soluble. Representative examples showed rapid and reversible binding to immobilized mouse perforin at low concentrations (≤2.5 μM) by surface plasmon resonance and prevented formation of perforin pores in target cells despite effective target cell engagement, as determined by calcium influx studies. Mouse PK studies of two analogues showed T1/2 values of 1.1–1.2 h (dose of 5 mg/kg iv) and MTDs of 60–80 mg/kg (ip).
Chemical Communications | 2006
Arnaud-Pierre Schaffner; Gersande Lena; Solveig Roussel; Anne Wawrezinieck; André Aubry; Jean-Paul Briand; Claude Didierjean; Gilles Guichard
Enantiopure dipeptide-derived 1,3,5-triazepan-2,6-diones and form H-bonded 3(1) helical molecular tapes with P chirality in the solid state; in the case of , these columnar tapes self-assemble through aromatic-aromatic interactions to give hollow tubular structures.
Journal of Medicinal Chemistry | 2006
Pascal Muller; Gersande Lena; Eric Boilard; Sofiane Bezzine; Gérard Lambeau; and Gilles Guichard; Didier Rognan
Chemistry: A European Journal | 2006
Gersande Lena; Eliette Lallemand; Anne Charlotte Grüner; Joel Boeglin; Solveig Roussel; Arnaud-Pierre Schaffner; André Aubry; Jean-François Franetich; Dominique Mazier; I. Landau; Jean-Paul Briand; Claude Didierjean; Laurent Rénia; Gilles Guichard
Current Organic Chemistry | 2008
Gersande Lena; Gilles Guichard
Archive | 2006
Gilles Guichard; Gersande Lena; Pascal Muller; Didier Rognan; Gérard Lambeau; Eric Boilard
Acta Crystallographica Section E-structure Reports Online | 2007
Emmanuel Aubert; Gersande Lena; Martine Gellenoncourt; Eric Durain; Gilles Guichard; Claude Didierjean
Advances in Experimental Medicine and Biology | 2009
Gilles Guichard; Gersande Lena; Joel Boeglin; Pascal Muller; Eric Boilard; Gérard Lambeau; Didier Rognan; Claude Didierjean
Archive | 2006
Guichard Gilles; Gersande Lena; Eliette Lallemand; Laurent Rénia